Redeye updates on Evolution post Q2-results which came in slightly lower than expected. While we trim our estimates (2022-24E EBITDA down c. 2-3%) due to slower than expected growth in Asia, we are positive to the solid growth in US and the increased share of regulated revenue.
LÄS MER